CN101912484A - Chinese medicinal composition for treating hypertension, hyperlipidemia and hyperglycemia - Google Patents
Chinese medicinal composition for treating hypertension, hyperlipidemia and hyperglycemia Download PDFInfo
- Publication number
- CN101912484A CN101912484A CN2010102441566A CN201010244156A CN101912484A CN 101912484 A CN101912484 A CN 101912484A CN 2010102441566 A CN2010102441566 A CN 2010102441566A CN 201010244156 A CN201010244156 A CN 201010244156A CN 101912484 A CN101912484 A CN 101912484A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- hyperlipidemia
- hyperglycemia
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a Chinese medicinal composition for treating hypertension, hyperlipidemia and hyperglycemia, which is prepared from the following raw material medicaments: kudzuvine root, root of red-rooted salvia, angelica dahurlica, ligusticum sinense oliver, flos chrysanthemi, sea-ear shell, cassia seed, astragalus, szechwon tangshen root, large-headed atractylodes rhizome, poria, liquoric root, platycladi seed, Chinese angelica, Chinese magnoliavine fruit, szechuan lovage rhizome, ginkgo leaf, tea leaf and raw hawthorn fruit. The Chinese medicinal composition has the good effects of reducing blood pressure, blood fat and blood sugar, preventing and treating arteriosclerosis and improving blood circulation, and has excellent prevention and treatment effect on cardiovascular and cerebrovascular diseases.
Description
Technical field
The invention belongs to medical technical field, be specifically related to a kind of Chinese medicine composition for the treatment of hypertension, hyperlipidemia and hyperglycemia.
Background technology
Present owing to growth in the living standard, the quickening of work rhythm and the variation of dietary structure, hypertension, hyperlipidemia and hyperglycemia become the commonly encountered diseases among the human lives, and number of the infected increases year by year, and the therapeutic effect of Most patients is all undesirable.Though this sick Western medicine relief of symptoms of existing treatment is rapid, the relapse rate height, and will rebound after the drug withdrawal, and existing Chinese medicine curative effect is not remarkable, medicining cycle is long, and less on the market, cures the symptoms, not the disease.
Summary of the invention
The objective of the invention is for overcoming disadvantages of background technology, provide a kind of and have blood pressure lowering preferably, blood fat reducing, blood sugar lowering, prevent and treat arteriosclerosis, improve sanguimotor effect, and cardiovascular and cerebrovascular disease is had the Chinese medicine composition of good preventive and therapeutic effect.
To achieve these goals, the technical solution used in the present invention is: a kind of Chinese medicine composition for the treatment of hypertension, hyperlipidemia and hyperglycemia, it is characterized in that, and make by following bulk drugs:
Radix Puerariae 10-50 part Radix Salviae Miltiorrhizae 10-50 part Radix Angelicae Dahuricae 10-50 part
Rhizoma Ligustici 10-50 part Flos Chrysanthemi 10-50 part Concha Haliotidis 10-50 part
Semen Cassiae 10-50 part Radix Astragali 10-50 part Radix Codonopsis 10-50 part
Rhizoma Atractylodis Macrocephalae 10-50 part Poria 10-50 part Radix Glycyrrhizae 10-20 part
Semen Platycladi 10-50 part Radix Angelicae Sinensis 10-50 part Fructus Schisandrae Chinensis 10-50 part
Rhizoma Chuanxiong 10-50 part Folium Ginkgo 10-50 part Folium Camelliae sinensis 3-10 part
Fructus Crataegi 10-50 part.
Above-mentioned a kind of Chinese medicine composition for the treatment of hypertension, hyperlipidemia and hyperglycemia is characterized in that, is made by following bulk drugs:
Radix Puerariae 20-40 part Radix Salviae Miltiorrhizae 20-40 part Radix Angelicae Dahuricae 20-40 part
Rhizoma Ligustici 20-40 part Flos Chrysanthemi 20-40 part Concha Haliotidis 20-40 part
Semen Cassiae 20-40 part Radix Astragali 20-40 part Radix Codonopsis 20-40 part
Rhizoma Atractylodis Macrocephalae 20-40 part Poria 20-40 part Radix Glycyrrhizae 12-18 part
Semen Platycladi 20-40 part Radix Angelicae Sinensis 20-40 part Fructus Schisandrae Chinensis 20-40 part
Rhizoma Chuanxiong 20-40 part Folium Ginkgo 20-40 part Folium Camelliae sinensis 5-10 part
Fructus Crataegi 20-40 part.
Above-mentioned a kind of Chinese medicine composition for the treatment of hypertension, hyperlipidemia and hyperglycemia, it is characterized in that, make: 33.6 parts of Radix Puerariaes, 28.0 parts of Radix Salviae Miltiorrhizaes, 27.4 parts of the Radixs Angelicae Dahuricae, 26.5 parts of Rhizoma Ligustici, 30.0 parts of Flos Chrysanthemis, 28.7 parts of Concha Haliotidis, 32.5 parts of Semen Cassiaes, 28.0 parts of the Radixs Astragali, 36.5 parts of Radix Codonopsis, 32.7 parts of the Rhizoma Atractylodis Macrocephalaes, 23.6 parts of Poria, 14.3 parts in Radix Glycyrrhizae, 36.7 parts of Semen Platycladi, 32.8 parts of Radix Angelicae Sinensis, 31.6 parts of Fructus Schisandrae Chinensis, 29.8 parts of Rhizoma Chuanxiongs, 32.0 parts of Folium Ginkgos, 6.5 parts of Folium Camelliae sinensis, 26.8 parts of Fructus Crataegi by the crude drug of following preferred weight part.
The dosage form of above-mentioned Chinese medicine composition is health tea or oral liquid.
Described weight portion can be weight metering units such as gram, two, jin, kilogram, ton.
The full side of the present invention has the effect of blood circulation promoting and blood stasis dispelling, regulating QI to relieve pain, expansion coronary vasodilator, blood flow increasing, blood viscosity lowering, blood sugar control, blood fat reducing.
The present invention compared with prior art has the following advantages: the present invention has blood pressure lowering preferably, blood fat reducing, blood sugar lowering, prevents and treats arteriosclerosis, improves sanguimotor effect, and cardiovascular and cerebrovascular disease is had good preventive and therapeutic effect.Health tea is easy to carry, but long-term drink is without any side effects, has the immunity of raising, health preserving, health-care effect; The oral liquid health absorbs fast, and the effect ofactivating blood circulation to dissipate blood stasis is good, and to other organ nonhazardous effects, curative effect is obvious, simultaneously hypertension sequela patient symptom is had mitigation capability.
The specific embodiment
Embodiment 1
The used crude drug of present embodiment is Radix Puerariae 50g, Radix Salviae Miltiorrhizae 20g, Radix Angelicae Dahuricae 28g, Rhizoma Ligustici 20g, Flos Chrysanthemi 35g, Concha Haliotidis 40g, Semen Cassiae 20g, Radix Astragali 40g, Radix Codonopsis 35g, Rhizoma Atractylodis Macrocephalae 25g, Poria 10g, Radix Glycyrrhizae 12g, Semen Platycladi 40g, Radix Angelicae Sinensis 20g, Fructus Schisandrae Chinensis 50g, Rhizoma Chuanxiong 40g, Folium Ginkgo 30g, Folium Camelliae sinensis 5g, Fructus Crataegi 30g.
Present embodiment adopts health tea preparation technology:
(1) takes by weighing the medical material of respectively distinguishing the flavor of by weight;
(2) each flavor medical material is carried out decontamination, cleaning, mixing the medical material after cleaning also, the water Steam Heating made the medical material ripening in 20 minutes; It is 0.01MPa that medical material after the ripening is placed vacuum, and temperature is 85 ℃ a vacuum drying oven inner drying 20 minutes;
(3) dried medical material in the step (2) is added water heating lixiviate twice, amount of water is: dried medical material: water=1: 5, heating-up temperature are 80 ℃, and be 2 hours heat time heating time for the first time, and be 1 hour heat time heating time for the second time; Merge extracted twice liquid, remove by filter impurity; Is 0.05MPa with the extracting solution after merging in vacuum, and temperature is to carry out vacuum concentration under 60 ℃ of conditions, makes extractum;
(4) with the oven dry of the extractum in the step (3), bake out temperature is 110 ℃, pulverize then, pack, and every bag of 10g, every 10g contains crude drug in whole 3g.
Embodiment 2
The used crude drug of present embodiment is Radix Puerariae 20g, Radix Salviae Miltiorrhizae 50g, Radix Angelicae Dahuricae 20g, Rhizoma Ligustici 50g, Flos Chrysanthemi 20g, Concha Haliotidis 20g, Semen Cassiae 40g, Radix Astragali 20g, Radix Codonopsis 10g, Rhizoma Atractylodis Macrocephalae 40g, Poria 20g, Radix Glycyrrhizae 18g, Semen Platycladi 20g, Radix Angelicae Sinensis 40g, Fructus Schisandrae Chinensis 30g, Rhizoma Chuanxiong 50g, Folium Ginkgo 40g, Folium Camelliae sinensis 8g, Fructus Crataegi 10g.
Present embodiment preparation technology is with embodiment 1.
Embodiment 3
The used crude drug of present embodiment is Radix Puerariae 30g, Radix Salviae Miltiorrhizae 30g, Radix Angelicae Dahuricae 40g, Rhizoma Ligustici 30g, Flos Chrysanthemi 40g, Concha Haliotidis 30g, Semen Cassiae 30g, Radix Astragali 30g, Radix Codonopsis 40g, Rhizoma Atractylodis Macrocephalae 20g, Poria 50g, Radix Glycyrrhizae 15g, Semen Platycladi 10g, Radix Angelicae Sinensis 30g, Fructus Schisandrae Chinensis 40g, Rhizoma Chuanxiong 30g, Folium Ginkgo 50g, Folium Camelliae sinensis 10g, Fructus Crataegi 20g.
Present embodiment preparation technology is with embodiment 1.
Embodiment 4
The used crude drug of present embodiment is Radix Puerariae 33.6g, Radix Salviae Miltiorrhizae 28.0g, Radix Angelicae Dahuricae 27.4g, Rhizoma Ligustici 26.5g, Flos Chrysanthemi 30.0g, Concha Haliotidis 28.7g, Semen Cassiae 32.5g, Radix Astragali 28.0g, Radix Codonopsis 36.5g, Rhizoma Atractylodis Macrocephalae 32.7g, Poria 23.6g, Radix Glycyrrhizae 14.3g, Semen Platycladi 36.7g, Radix Angelicae Sinensis 32.8g, Fructus Schisandrae Chinensis 31.6g, Rhizoma Chuanxiong 29.8g, Folium Ginkgo 32.0g, Folium Camelliae sinensis 6.5g, Fructus Crataegi 26.8g.
Present embodiment adopts oral liquid preparation technology:
(1) takes by weighing the medical material of respectively distinguishing the flavor of by weight;
(2) except that Folium Camelliae sinensis, other medical material of respectively distinguishing the flavor of is cleaned, cuts into slices, mixes, mixed medical material and Folium Camelliae sinensis are decocted with water, amount of water is: mixed medical material: water=1: 8, extract decocting liquid; Is 0.05MPa with the decocting liquid that extracts in vacuum, and temperature is to carry out vacuum concentration under 50 ℃ of conditions, makes thick paste;
(3) adding volume fraction in the spissated thick paste in step (2) is 75% ethanol, and the ethanol consumption is 1000mL, soaking at room temperature 40 hours; Collect the medicinal liquid after alcohol-pickled, in medicinal liquid, add 100g sucrose, and add water and adjust the medicinal liquid total amount to 3000mL;
(4) medicinal liquid that adds sucrose and water in the step (3) is distilled under 85 ℃ of conditions remove ethanol, go medicinal residues, filtration then; Filtered liquid medicine is sterilized, bottled, every bottle of 20mL, every 20mL contains crude drug in whole 3g.
Embodiment 5
The used crude drug of present embodiment is Radix Puerariae 33g, Radix Salviae Miltiorrhizae 40g, Radix Angelicae Dahuricae 30g, Rhizoma Ligustici 35g, Flos Chrysanthemi 30g, Concha Haliotidis 10g, Semen Cassiae 50g, Radix Astragali 33g, Radix Codonopsis 30g, Rhizoma Atractylodis Macrocephalae 30g, Poria 36g, Radix Glycyrrhizae 10g, Semen Platycladi 30g, Radix Angelicae Sinensis 50g, Fructus Schisandrae Chinensis 30g, Rhizoma Chuanxiong 20g, Folium Ginkgo 28g, Folium Camelliae sinensis 7g, Fructus Crataegi 36g.
Present embodiment preparation technology is with embodiment 4.
Embodiment 6
The used crude drug of present embodiment is Radix Puerariae 40g, Radix Salviae Miltiorrhizae 10g, Radix Angelicae Dahuricae 10g, Rhizoma Ligustici 40g, Flos Chrysanthemi 50g, Concha Haliotidis 32g, Semen Cassiae 10g, Radix Astragali 50g, Radix Codonopsis 20g, Rhizoma Atractylodis Macrocephalae 50g, Poria 30g, Radix Glycyrrhizae 14g, Semen Platycladi 33g, Radix Angelicae Sinensis 35g, Fructus Schisandrae Chinensis 10g, Rhizoma Chuanxiong 38g, Folium Ginkgo 10g, Folium Camelliae sinensis 7.5g, Fructus Crataegi 50g.
Present embodiment preparation technology is with embodiment 4.
Embodiment 7
The used crude drug of present embodiment is Radix Puerariae 10g, Radix Salviae Miltiorrhizae 22g, Radix Angelicae Dahuricae 50g, Rhizoma Ligustici 10g, Flos Chrysanthemi 10g, Concha Haliotidis 50g, Semen Cassiae 35g, Radix Astragali 10g, Radix Codonopsis 50g, Rhizoma Atractylodis Macrocephalae 10g, Poria 40g, Radix Glycyrrhizae 20g, Semen Platycladi 50g, Radix Angelicae Sinensis 10g, Fructus Schisandrae Chinensis 20g, Rhizoma Chuanxiong 10g, Folium Ginkgo 50g, Folium Camelliae sinensis 3g, Fructus Crataegi 40g.
Present embodiment preparation technology is with embodiment 4.
Usage and dosage: health tea is soaked with boiled water and takes the every day and the same unrestricted the drinking of drinking water; Oral liquid is taken 3 times every day, each 1, takes in 1 hour after meal.
Curative effect determinate standard: the patient does not have dizziness, headache, feeling of fullness in the head sensation, and the index of correlation such as blood pressure, blood viscosity, blood fat, blood glucose are normal, and daily life is normal, and self care ability obviously strengthens.
Invalid: and compare before the treatment, each side does not have any progress.
General clinical data: this group case is totally 260 examples, and 200 examples are organized in treatment, matched group 60 examples.Wherein, the treatment group is sick plants: hypertension 100 examples, hyperlipidemia 50 examples, hyperglycemia 50 examples.Drink health tea 120 examples, hypertension 60 examples wherein, hyperlipidemia 30 examples, hyperglycemia 30 examples; Take oral liquid 80 examples, hypertension 40 examples wherein, hyperlipidemia 20 examples, hyperglycemia 20 examples.Matched group is sick plants: hypertension 20 examples, and hyperlipidemia 20 examples, hyperglycemia 20 examples, wherein the hyperpietic takes the captopril sheet, and hyperlipemic patients is taken the inositol niacinate sheet, and hyperglycemic patients is taken glipizide tablet.
Table 1 liang group curative effect situation contrast
Clinical observation case 260 examples of the present invention, wherein 200 examples are organized in treatment, matched group 60 examples, the treatment group adopts health tea of the present invention and oral liquid, wherein drinks health tea 120 examples, the every day and the same unrestricted the drinking of drinking water; Take oral liquid 80 examples, oral, every day 3 times, each 1, take 1 hour ante cibum; Matched group adopts routine medication, and wherein the hyperpietic takes the captopril sheet, and hyperlipemic patients is taken the inositol niacinate sheet, and hyperglycemic patients is taken glipizide tablet, conventional amount used administration shown in the usage by specification.Treatment group and matched group general curative effect are relatively, its result drinks health tea 120 examples in the treatment group, drink the index of correlation index decreased of having a medical check-up after 1 month, still adhere at present taking, the pressure of having a blood test, blood fat, blood viscosity, blood glucose are all normal, hypertension 60 examples wherein, cure 55 examples, account for 91.67%, effective 5 examples, account for 8.33%, total effective rate 100%; Hyperlipidemia 30 examples, produce effects 25 examples account for 83.33%, and effective 5 examples account for 16.67%, total effective rate 100%; Hyperglycemia 30 examples, produce effects 20 examples account for 66.67%, and effective 10 examples account for 33.33%, total effective rate 100%.Take oral liquid 80 examples, wherein hypertension 40 examples are cured 30 examples, account for 75%, and produce effects 10 examples account for 25%, total effective rate 100%; Hyperlipidemia 20 examples, produce effects 20 examples account for 100%, total effective rate 100%; Hyperglycemia 20 examples, produce effects 15 examples account for 75%, and effective 5 examples account for 25%, total effective rate 100%.Matched group 60 examples, hypertension 20 examples wherein, the period in a medicine blood pressure is controlled, cure 10 examples, account for 50%, invalid 10 examples account for 50%, total effective rate 50%, mostly that cures is slight patient, and recurrence easily in the therapeutic process, just has a rebound after the drug withdrawal, major part is alleviated only, and problems such as the state of an illness increases the weight of, complication appear in a part of patient in therapeutic process; Hyperlipidemia 20 examples, most of patient's period in a medicine blood fat and blood viscosity are controlled, and produce effects 10 examples account for 50%, effective 5 examples, account for 25%, invalid 5 examples account for 25%, total effective rate 75%, recurrence easily in the therapeutic process, major part is alleviated only, and problems such as the state of an illness increases the weight of, complication appear in a part of patient in therapeutic process; Hyperglycemia 20 examples, part patient's period in a medicine blood glucose is controlled, produce effects 10 examples account for 50%, invalid 10 examples, account for 50%, total effective rate 50%, recurrence easily just has a rebound after the drug withdrawal in the therapeutic process, need take medicine for a long time, problem such as a part of patient occurs in therapeutic process that the state of an illness increases the weight of, untoward reaction and complication.Two groups relatively curative effect there were significant differences, Chinese medicine composition composition formula uniqueness of the present invention, cure rate height, relapse rate is low, stability is strong, have no side effect, treating both the principal and secondary aspects of a disease, do not develop complications after the patient takes, bad of recurrence etc. should, be fit to the medicine popularization of going on the market.
Model case
Case 1
Zhang, the man, 52 years old, live rice grain town, Zhenan County, go to a doctor on February 3rd, 2010.Readme headache, dizzy more than 5 years, cardiopalmus, insomnia, irritated irritability, soreness of the waist and knees are often accompanied in aggravation when tired or excited.Usual hobby tobacco and wine and pungent, taste is heavy.Blood pressure decreasing capsule, the blood pressure lowering of nitrendipine Western medicine are taken in readme, and symptom takes a turn for the better sometimes, but normal recurrence, 10 days causes are stayed up late and are caused headache, dizziness, irritated insomnia, soreness of the waist and knees, flushed face, purplish tongue, through measuring blood pressure 170/105mmng.Western medicine diagnose: essential hypertension.Take that Western medicine depressor symptom takes a turn for the better but not obvious, require treatment by Chinese herbs, after took the top oral liquid 2 months, further consultation readme headache, dizziness disappear substantially, through measuring, blood pressure 130/90mmng, after keep this side, continued to take 2 months, follow up a case by regular visits to after January, recur.
Case 2
Model, man, 48 years old, vehicle repairing factory cadre.First visit in April, 2004.The main suit had a headache dizzy 3 years, companion neck pain, tinnitus dim eyesight, xerostomia be desire drink, sleep dreaminess, lumbago and skelalgia, upper and lower extremities numbness, the tired power of body for a short time not, deep-thready pulse, light red tongue tongue are few, blood pressure 180/110mmng, lipid examination: cholesterol 6.2mm/L, triglyceride 2.14mm/L, B lipoprotein 11.08g/L, Western medicine diagnose is hyperlipidemia, arteriosclerosis, hypertension.Take poor effect such as troxerutin, change and to ask Chinese traditional treatment, dialectically be: the hepatic and renal YIN deficiency.Therapeutic scheme is enriching yin and nourishing kidney, promoting blood circulation to remove obstruction in the collateral, the side's of using oral liquid 3 months, and symptom is clearly better, and continues to take that symptom disappears substantially after 2 months, and stringy pulse is slow, tongue fur is red, and blood fat, blood pressure inspection are all reduced to normally, follow up a case by regular visits to for many years to recur.
Case 3
Feng, man, 62 years old, first visit on May 9 in 2004.Readme is dizzy, headache 3 years, each send out must distending pain, dare not speech, the tinnitus battle array does, dizzy, extremity are numb, upper limb more so.Through western medical treatment, all postpone symptom repeatly, then recurrence soon, flushed face, the few tongue of red tongue, stringy and thready pulse, blood pressure 22.9/13.3kPa, blood fat 6.6mm/L, cholesterol 6.8mm/L.Take top oral liquid after 1 month, headache remission, but still few dizzy, after add and take 3 months, all transference cures, after follow up a case by regular visits to for many years recurrence.
Case 4
High certain, man, 55 years old.Be diagnosed as diabetes in 2000, fasting glucose 8.2mm/L, 2 hours after the meal blood glucose 12.6mm/L, in December, 2003 sleep in evening is asymptomatic, facial hemiparalysis takes place, the right side hemiplegia morning on next day, tongue is obstinate tongue-tied, is diagnosed as apoplexy, takes effect after 20 days through the side's of using oral liquid, continue to take after 3 months and can know speech, the back combines with Western medicine and takes, and adheres to drinking the top health tea, symptom takes a turn for the better, can get up to walk, still adhere at present taking, glycemic control be all right.
Case 5
Yuan, the man, 61 years old, blood pressure 22.9/13.3kPa had a dizzy spell, the right side numb hand and foot, blood viscosity 6.3 is the apoplexy omen, takes the top oral liquid 1 month, and subjective symptoms disappears, blood viscosity 4.2, blood pressure 18.3/12kPa continues to take and consolidated curative effect in 3 months, follows up a case by regular visits to not recurrence in 2 years.
Claims (4)
1. a Chinese medicine composition for the treatment of hypertension, hyperlipidemia and hyperglycemia is characterized in that, is made by following bulk drugs:
Radix Puerariae 10-50 part Radix Salviae Miltiorrhizae 10-50 part Radix Angelicae Dahuricae 10-50 part
Rhizoma Ligustici 10-50 part Flos Chrysanthemi 10-50 part Concha Haliotidis 10-50 part
Semen Cassiae 10-50 part Radix Astragali 10-50 part Radix Codonopsis 10-50 part
Rhizoma Atractylodis Macrocephalae 10-50 part Poria 10-50 part Radix Glycyrrhizae 10-20 part
Semen Platycladi 10-50 part Radix Angelicae Sinensis 10-50 part Fructus Schisandrae Chinensis 10-50 part
Rhizoma Chuanxiong 10-50 part Folium Ginkgo 10-50 part Folium Camelliae sinensis 3-10 part
Fructus Crataegi 10-50 part.
2. a kind of Chinese medicine composition for the treatment of hypertension, hyperlipidemia and hyperglycemia according to claim 1 is characterized in that, is made by following bulk drugs:
Radix Puerariae 20-40 part Radix Salviae Miltiorrhizae 20-40 part Radix Angelicae Dahuricae 20-40 part
Rhizoma Ligustici 20-40 part Flos Chrysanthemi 20-40 part Concha Haliotidis 20-40 part
Semen Cassiae 20-40 part Radix Astragali 20-40 part Radix Codonopsis 20-40 part
Rhizoma Atractylodis Macrocephalae 20-40 part Poria 20-40 part Radix Glycyrrhizae 12-18 part
Semen Platycladi 20-40 part Radix Angelicae Sinensis 20-40 part Fructus Schisandrae Chinensis 20-40 part
Rhizoma Chuanxiong 20-40 part Folium Ginkgo 20-40 part Folium Camelliae sinensis 5-10 part
Fructus Crataegi 20-40 part.
3. a kind of Chinese medicine composition for the treatment of hypertension, hyperlipidemia and hyperglycemia according to claim 1, it is characterized in that, make: 33.6 parts of Radix Puerariaes, 28.0 parts of Radix Salviae Miltiorrhizaes, 27.4 parts of the Radixs Angelicae Dahuricae, 26.5 parts of Rhizoma Ligustici, 30.0 parts of Flos Chrysanthemis, 28.7 parts of Concha Haliotidis, 32.5 parts of Semen Cassiaes, 28.0 parts of the Radixs Astragali, 36.5 parts of Radix Codonopsis, 32.7 parts of the Rhizoma Atractylodis Macrocephalaes, 23.6 parts of Poria, 14.3 parts in Radix Glycyrrhizae, 36.7 parts of Semen Platycladi, 32.8 parts of Radix Angelicae Sinensis, 31.6 parts of Fructus Schisandrae Chinensis, 29.8 parts of Rhizoma Chuanxiongs, 32.0 parts of Folium Ginkgos, 6.5 parts of Folium Camelliae sinensis, 26.8 parts of Fructus Crataegi by following bulk drugs.
4. according to claim 1,2 or 3 described a kind of Chinese medicine compositions for the treatment of hypertension, hyperlipidemia and hyperglycemia, it is characterized in that the dosage form of described Chinese medicine composition is health tea or oral liquid.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010102441566A CN101912484B (en) | 2010-08-02 | 2010-08-02 | Chinese medicinal composition for treating hypertension, hyperlipidemia and hyperglycemia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010102441566A CN101912484B (en) | 2010-08-02 | 2010-08-02 | Chinese medicinal composition for treating hypertension, hyperlipidemia and hyperglycemia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101912484A true CN101912484A (en) | 2010-12-15 |
| CN101912484B CN101912484B (en) | 2012-01-11 |
Family
ID=43320231
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010102441566A Expired - Fee Related CN101912484B (en) | 2010-08-02 | 2010-08-02 | Chinese medicinal composition for treating hypertension, hyperlipidemia and hyperglycemia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101912484B (en) |
Cited By (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102488769A (en) * | 2011-12-16 | 2012-06-13 | 王立财 | Diet pill |
| CN102657278A (en) * | 2012-05-30 | 2012-09-12 | 劳子明 | Asparagus healthcare tea |
| CN102742691A (en) * | 2012-07-24 | 2012-10-24 | 刘建生 | Health-care tea drink with blood pressure lowering effect and preparation method thereof |
| CN102824059A (en) * | 2012-09-19 | 2012-12-19 | 宁波邦臣电子商务有限公司 | Water heating mattress and poling process thereof |
| CN103013806A (en) * | 2012-12-07 | 2013-04-03 | 路修憬 | Health-care therapeutic herbal vinegar |
| CN103212044A (en) * | 2013-04-08 | 2013-07-24 | 姜玉芝 | Traditional Chinese medicine composition for treating cardiovascular diseases |
| CN103300367A (en) * | 2013-06-08 | 2013-09-18 | 山西省肿瘤研究所 | Health care drink with lipid-decreasing function and preparation method thereof |
| CN103392880A (en) * | 2013-08-08 | 2013-11-20 | 常熟市海虞茶叶有限公司 | Medical health-care tea leaves |
| CN103505565A (en) * | 2013-09-27 | 2014-01-15 | 张娟 | Health protection medicine with efficacy of regulating blood lipid and preparation method thereof |
| CN103719409A (en) * | 2012-10-16 | 2014-04-16 | 广西北流市一品黑土特产销售中心 | Healthcare tea |
| CN103948901A (en) * | 2014-05-18 | 2014-07-30 | 郑家林 | Traditional Chinese medicine preparation for lowering blood fat |
| CN103977332A (en) * | 2014-05-18 | 2014-08-13 | 郑家林 | Traditional Chinese medicine preparation capable of reducing blood fat |
| CN105077470A (en) * | 2015-07-16 | 2015-11-25 | 宁夏天瑞产业集团现代农业有限公司 | Blood fat lowering beverage and production method thereof |
| CN107441401A (en) * | 2017-09-25 | 2017-12-08 | 魏增强 | Chinese medicine composition for three high drop and preparation method thereof |
| CN109699790A (en) * | 2019-02-28 | 2019-05-03 | 周栖 | A kind of health protection tea with antihypertensive, hyperglycemia and hyperlipidemia effect |
| CN113082165A (en) * | 2021-04-26 | 2021-07-09 | 北京同德利华科技有限责任公司 | Composition for assisting in reducing hypertension, hyperglycemia and hyperlipidemia and preparation method and application thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1868532A (en) * | 2005-05-23 | 2006-11-29 | 邓大勇 | Medicine for treating hypertension |
| CN101274084A (en) * | 2007-12-18 | 2008-10-01 | 秦庆吉 | Medicament for curing hypertension, hyperlipemia and complication thereof |
| CN101513492A (en) * | 2008-02-22 | 2009-08-26 | 北京天科仁祥医药科技有限公司 | Chinese medicament for treating diabetes |
-
2010
- 2010-08-02 CN CN2010102441566A patent/CN101912484B/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1868532A (en) * | 2005-05-23 | 2006-11-29 | 邓大勇 | Medicine for treating hypertension |
| CN101274084A (en) * | 2007-12-18 | 2008-10-01 | 秦庆吉 | Medicament for curing hypertension, hyperlipemia and complication thereof |
| CN101513492A (en) * | 2008-02-22 | 2009-08-26 | 北京天科仁祥医药科技有限公司 | Chinese medicament for treating diabetes |
Non-Patent Citations (2)
| Title |
|---|
| 《光明中医》 20090228 梁凤莲等 高脂血症的中医药辨证论治 第24卷, 第2期 2 * |
| 《长春中医药大学学报》 20070228 刘泽延 2型糖尿病伴高血压病的中西医结合治疗体会 第23卷, 第1期 2 * |
Cited By (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102488769A (en) * | 2011-12-16 | 2012-06-13 | 王立财 | Diet pill |
| CN102657278A (en) * | 2012-05-30 | 2012-09-12 | 劳子明 | Asparagus healthcare tea |
| CN102742691A (en) * | 2012-07-24 | 2012-10-24 | 刘建生 | Health-care tea drink with blood pressure lowering effect and preparation method thereof |
| CN102824059A (en) * | 2012-09-19 | 2012-12-19 | 宁波邦臣电子商务有限公司 | Water heating mattress and poling process thereof |
| CN102824059B (en) * | 2012-09-19 | 2015-05-13 | 宁波邦臣电子商务有限公司 | Water heating mattress and poling process thereof |
| CN103719409A (en) * | 2012-10-16 | 2014-04-16 | 广西北流市一品黑土特产销售中心 | Healthcare tea |
| CN103013806A (en) * | 2012-12-07 | 2013-04-03 | 路修憬 | Health-care therapeutic herbal vinegar |
| CN103013806B (en) * | 2012-12-07 | 2014-01-29 | 路修憬 | Health-care therapeutic herbal vinegar |
| CN103212044B (en) * | 2013-04-08 | 2015-04-01 | 周丽英 | Traditional Chinese medicine composition for treating cardiovascular diseases |
| CN103212044A (en) * | 2013-04-08 | 2013-07-24 | 姜玉芝 | Traditional Chinese medicine composition for treating cardiovascular diseases |
| CN103300367B (en) * | 2013-06-08 | 2014-07-09 | 山西省肿瘤研究所 | Health care drink with lipid-decreasing function and preparation method thereof |
| CN103300367A (en) * | 2013-06-08 | 2013-09-18 | 山西省肿瘤研究所 | Health care drink with lipid-decreasing function and preparation method thereof |
| CN103392880A (en) * | 2013-08-08 | 2013-11-20 | 常熟市海虞茶叶有限公司 | Medical health-care tea leaves |
| CN103505565A (en) * | 2013-09-27 | 2014-01-15 | 张娟 | Health protection medicine with efficacy of regulating blood lipid and preparation method thereof |
| CN103977332A (en) * | 2014-05-18 | 2014-08-13 | 郑家林 | Traditional Chinese medicine preparation capable of reducing blood fat |
| CN103948901A (en) * | 2014-05-18 | 2014-07-30 | 郑家林 | Traditional Chinese medicine preparation for lowering blood fat |
| CN103948901B (en) * | 2014-05-18 | 2016-05-04 | 朱长怀 | A kind of Chinese medicine preparation of reducing blood lipid |
| CN105077470A (en) * | 2015-07-16 | 2015-11-25 | 宁夏天瑞产业集团现代农业有限公司 | Blood fat lowering beverage and production method thereof |
| CN107441401A (en) * | 2017-09-25 | 2017-12-08 | 魏增强 | Chinese medicine composition for three high drop and preparation method thereof |
| CN109699790A (en) * | 2019-02-28 | 2019-05-03 | 周栖 | A kind of health protection tea with antihypertensive, hyperglycemia and hyperlipidemia effect |
| CN113082165A (en) * | 2021-04-26 | 2021-07-09 | 北京同德利华科技有限责任公司 | Composition for assisting in reducing hypertension, hyperglycemia and hyperlipidemia and preparation method and application thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101912484B (en) | 2012-01-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101912484B (en) | Chinese medicinal composition for treating hypertension, hyperlipidemia and hyperglycemia | |
| CN102078402B (en) | Traditional Chinese medicine composition for treating hypertension, hyperlipidemia and hyperglycemia | |
| CN103990081B (en) | Traditional Chinese medicine composition and application thereof in preparation of medicine for treating infant jaundice | |
| CN104666579A (en) | Traditional Chinese medicine composition for treating gonarthromeningitis and preparation method of traditional Chinese medicine composition | |
| CN103301267B (en) | Traditional Chinese medicine composition for treating hypertension and/or atherosclerosis and application thereof | |
| CN102940785B (en) | Traditional Chinese medicine composition for treating vertigo | |
| CN1141133C (en) | Chinese medicine for treating hypertension | |
| CN103749819B (en) | Fructus Corni health protection tea of a kind of hypoglycemic and preparation method thereof | |
| CN101199796B (en) | External antidiarrhoeal medicament, preparing method and function thereof | |
| CN104043077A (en) | Traditional Chinese medicine composition for tonifying qi and nourishing blood | |
| CN102920807A (en) | Herb tea for lowering blood pressure | |
| CN102846879A (en) | Composition for depressing blood fat | |
| CN105394282A (en) | Radix puerariae health tea capable of reducing blood pressure, blood sugar and blood lipid | |
| CN103285343B (en) | Medicine for treating liver cancer and preparation method thereof | |
| CN104353051A (en) | Traditional Chinese medicine preparation for treating stomachache and preparation method thereof | |
| CN104367926A (en) | Traditional Chinese medicine preparation for treating predawn diarrhea and preparation method thereof | |
| CN103877483A (en) | Traditional Chinese medicine for treating chronic gastritis and preparation method thereof | |
| CN103725587A (en) | Sealwort and hawthorn vinegar and production method thereof | |
| CN103463427B (en) | Medicinal tea for treating arteriosclerosis | |
| CN102846720B (en) | Composite for lowering blood fat and improving anoxia endurance | |
| CN105343688A (en) | Medicine composition for treating myocardial infarction and application thereof | |
| CN105410268A (en) | Semen cuscutae health-care tea capable of improving eyesight and reducing blood lipid and preparation method of semen cuscutae health-care tea | |
| CN105056170A (en) | Application of traditional Chinese medicine composition in preparing drug for treating acute gastritis | |
| CN1280835A (en) | Chinese-medicinal capsule for treating hyperlipomia | |
| CN104127670A (en) | Traditional Chinese medicine decoction for treating arrhythmia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120111 Termination date: 20140802 |
|
| EXPY | Termination of patent right or utility model |